Traders Sell Johnson & Johnson (JNJ) on Strength (JNJ)

Investors sold shares of Johnson & Johnson (NYSE:JNJ) on strength during trading hours on Thursday. $146.21 million flowed into the stock on the tick-up and $208.58 million flowed out of the stock on the tick-down, for a money net flow of $62.37 million out of the stock. Of all companies tracked, Johnson & Johnson had the 0th highest net out-flow for the day. Johnson & Johnson traded up $1.56 for the day and closed at $131.23

JNJ has been the subject of several recent research reports. Vetr raised shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $150.89 price target for the company in a research note on Thursday, January 11th. Royal Bank of Canada reissued a “buy” rating on shares of Johnson & Johnson in a research note on Tuesday, January 9th. Citigroup boosted their price target on shares of Johnson & Johnson from $140.00 to $149.00 and gave the stock a “buy” rating in a research note on Monday, October 23rd. Zacks Investment Research downgraded shares of Johnson & Johnson from a “buy” rating to a “hold” rating in a research note on Tuesday, December 12th. Finally, Credit Suisse Group set a $154.00 price target on shares of Johnson & Johnson and gave the stock a “hold” rating in a research note on Monday, January 22nd. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. Johnson & Johnson presently has a consensus rating of “Hold” and a consensus price target of $146.16.

The firm has a market capitalization of $357,710.00, a PE ratio of 341.41, a PEG ratio of 2.20 and a beta of 0.74. The company has a current ratio of 1.32, a quick ratio of 1.02 and a debt-to-equity ratio of 0.36.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings data on Tuesday, January 23rd. The company reported $1.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.02. Johnson & Johnson had a net margin of 1.70% and a return on equity of 27.80%. The firm had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.08 billion. During the same quarter in the previous year, the company earned $1.58 earnings per share. The company’s revenue for the quarter was up 11.5% compared to the same quarter last year. equities research analysts forecast that Johnson & Johnson will post 8.11 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Tuesday, February 27th will be given a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.52%. The ex-dividend date of this dividend is Monday, February 26th. Johnson & Johnson’s payout ratio is 861.54%.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Goodman Financial Corp purchased a new stake in Johnson & Johnson in the fourth quarter worth about $104,000. Harding Loevner LP purchased a new stake in Johnson & Johnson in the second quarter worth about $106,000. Stelac Advisory Services LLC purchased a new stake in Johnson & Johnson in the fourth quarter worth about $108,000. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its holdings in Johnson & Johnson by 29.9% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 870 shares of the company’s stock worth $115,000 after purchasing an additional 200 shares during the period. Finally, IHT Wealth Management LLC grew its holdings in Johnson & Johnson by 46.4% in the second quarter. IHT Wealth Management LLC now owns 10,942 shares of the company’s stock worth $122,000 after purchasing an additional 3,467 shares during the period. Institutional investors own 65.53% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This news story was reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this news story on another domain, it was copied illegally and republished in violation of international copyright and trademark legislation. The legal version of this news story can be read at https://ledgergazette.com/2018/02/17/traders-sell-johnson-johnson-jnj-on-strength-jnj.html.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply